- Home
- WLY vs AZTA Comparison
WLY vs AZTA Comparison
Compare WLY & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLY
- AZTA
- Stock Information
- Founded
- WLY 1807
- AZTA 1978
- Country
- WLY United States
- AZTA United States
- Employees
- WLY N/A
- AZTA N/A
- Industry
- WLY Books
- AZTA Industrial Machinery/Components
- Sector
- WLY Consumer Discretionary
- AZTA Technology
- Exchange
- WLY Nasdaq
- AZTA Nasdaq
- Market Cap
- WLY 2.2B
- AZTA 1.8B
- IPO Year
- WLY N/A
- AZTA 1995
- Fundamental
- Price
- WLY $41.75
- AZTA $29.25
- Analyst Decision
- WLY
- AZTA Buy
- Analyst Count
- WLY 0
- AZTA 4
- Target Price
- WLY N/A
- AZTA $58.75
- AVG Volume (30 Days)
- WLY 578.2K
- AZTA 712.7K
- Earning Date
- WLY 03-06-2025
- AZTA 05-07-2025
- Dividend Yield
- WLY 3.18%
- AZTA N/A
- EPS Growth
- WLY N/A
- AZTA N/A
- EPS
- WLY 0.75
- AZTA N/A
- Revenue
- WLY $1,703,491,000.00
- AZTA $662,108,000.00
- Revenue This Year
- WLY N/A
- AZTA N/A
- Revenue Next Year
- WLY $1.13
- AZTA $5.44
- P/E Ratio
- WLY $60.63
- AZTA N/A
- Revenue Growth
- WLY N/A
- AZTA 5.36
- 52 Week Low
- WLY $34.85
- AZTA $31.09
- 52 Week High
- WLY $53.96
- AZTA $63.58
- Technical
- Relative Strength Index (RSI)
- WLY 44.47
- AZTA 22.62
- Support Level
- WLY $43.96
- AZTA $33.33
- Resistance Level
- WLY $45.56
- AZTA $35.80
- Average True Range (ATR)
- WLY 0.87
- AZTA 1.76
- MACD
- WLY -0.25
- AZTA -0.33
- Stochastic Oscillator
- WLY 18.84
- AZTA 1.74
About WLY John Wiley & Sons Inc.
John Wiley & Sons Inc is a provider of academic journals, books, pre- and post-hire assessments and training, test preparation materials, and online education program management solutions. The company's reportable segments are; Research, Learning, Held for Sale or Sold. The majority of the company's revenue is generated from the Research segment which provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Geographically, it derives maximum revenue from the United States and the rest from the United Kingdom, China, Japan, Canada, and other countries.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.